Internal Medicine
Remdesivir for the treatment of Covid-19 — final report
9 Oct, 2020 | 09:13h | UTCRemdesivir for the Treatment of Covid-19 — Final Report – New England Journal of Medicine
Commentary: BREAKING NEWS: Final remdesivir results published after 139 days of waiting – Brief19
Commentary on Twitter
📍Remdesivir trial (ACTT-1) final results finally out.
📍Still no mortality benefit. A study with tons of patients could show some small mortality benefit.
📍Those who recover, do so a bit faster.
📍Not the game-changer that was hyped.via @Brief_19https://t.co/jWRJypJIuS
— Jeremy Faust MD MS (ER physician) (@jeremyfaust) October 8, 2020
[News release – not published yet] Eli Lilly says its monoclonal antibody cocktail is effective in treating Covid-19
9 Oct, 2020 | 09:09h | UTCEli Lilly says its monoclonal antibody cocktail is effective in treating Covid-19 – STAT
As we fight the coronavirus pandemic, we cannot ignore non-communicable diseases
9 Oct, 2020 | 09:08h | UTCAs We Fight The Coronavirus Pandemic, We Cannot Ignore Non-Communicable Diseases – Forbes
Study: Neurologic manifestations occur in most hospitalized Covid‐19 patients
9 Oct, 2020 | 09:11h | UTCCommentaries: COVID-19 neurological symptoms emerge in most hospitalized patients, study says AND Many hospitalized COVID-19 patients exhibit neurological symptoms, study finds – News Medical AND More than 80% of people hospitalized for COVID-19 suffer neurological symptoms, from confusion to altered brain function – Business Insider
Non-invasive positive pressure ventilation in patients with COVID-19
9 Oct, 2020 | 08:58h | UTCNon-Invasive Positive Pressure Ventilation in Patients With COVID-19 – Mayo Clinic Proceedings
Randomized trial: Effect of exercise training for five years on all cause mortality in older adults
9 Oct, 2020 | 08:56h | UTCNews Release: Exercise intensity not linked to mortality risk in older adults, finds trial – BMJ
Infographic: Generation 100 study: randomised controlled trial
Commentary: It’s never too late for older adults to start exercising – The BMJ Opinion
Commentaries on Twitter
Impressive study — 5yr #exercise RCT looking at all cause mortality in over 1500 older adults (~73yo). Adherence to exercise ~50%. @bmj_latest https://t.co/UnthYld2bM pic.twitter.com/t4JMQXiD78
— Jess Scott, PhD (@cardiac_fitness) October 8, 2020
Exercise intensity appears to make no difference to risk of mortality among older adults, suggests a randomised controlled trial from Norway published by @bmj_latest today https://t.co/7h7hzPTymf @UWisloff
— BMJ Group (@bmj_company) October 8, 2020
Systematic review: Not enough evidence to recommend vena caval filters for the prevention of pulmonary embolism
9 Oct, 2020 | 08:52h | UTCVena caval filters for the prevention of pulmonary embolism – Cochrane Library
Summary: Vena caval filters for the prevention of pulmonary embolism – Cochrane Library
Editorial: The ten reasons why corticosteroid therapy reduces mortality in severe COVID-19
8 Oct, 2020 | 09:15h | UTC
ATS/ERS Updated guidance on the management of COVID-19
8 Oct, 2020 | 09:16h | UTC
Editorial – Long COVID: let patients help define long-lasting COVID symptoms
8 Oct, 2020 | 09:09h | UTCLong COVID: let patients help define long-lasting COVID symptoms – Nature
What is post-viral fatigue syndrome, the condition affecting some COVID-19 survivors?
8 Oct, 2020 | 09:08h | UTC
5 things to know about a COVID vaccine: It won’t be a ‘magic wand’
8 Oct, 2020 | 09:05h | UTC5 Things to Know About a COVID Vaccine: It Won’t Be a ‘Magic Wand’ – Kaiser Health News
Why people with diabetes are being hit so hard by Covid-19
8 Oct, 2020 | 09:04h | UTCWhy people with diabetes are being hit so hard by Covid-19 – STAT
[Abstract Only] Interferon Beta-1b and Lopinavir–Ritonavir for Middle East Respiratory Syndrome
8 Oct, 2020 | 08:59h | UTCInterferon Beta-1b and Lopinavir–Ritonavir for Middle East Respiratory Syndrome – New England Journal of Medicine (link to abstract – $ for full-text)
COVID-19 and the kidney
8 Oct, 2020 | 09:02h | UTCCOVID-19 and the kidney – Cleveland Clinic Journal of Medicine
Meta-analysis: Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with Type 2 diabetes
8 Oct, 2020 | 08:57h | UTC
Expert analysis: Very low carbohydrate and ketogenic diets and cardiometabolic risk
8 Oct, 2020 | 08:58h | UTCVery Low Carbohydrate and Ketogenic Diets and Cardiometabolic Risk – American College of Cardiology
Randomized trial: Lopinavir–ritonavir not beneficial for patients admitted to hospital with COVID-19
7 Oct, 2020 | 08:50h | UTCCommentaries: Study: HIV drug of no benefit to hospitalized COVID patients – CIDRAP AND Antiviral monotherapy for hospitalised patients with COVID-19 is not enough – The Lancet AND
Commentary on Twitter
NEW—Lopinavir-ritonavir is not an effective treatment for patients hospitalised with #COVID19: finding from RECOVERY, randomised, controlled, open-label, platform trial https://t.co/RpiUAvWF1I pic.twitter.com/uI3yiQbEgK
— The Lancet (@TheLancet) October 6, 2020
ACEP Clinical Policy: Critical issues related to opioids in adult patients presenting to the emergency department
8 Oct, 2020 | 08:53h | UTCCommentary: ACEP Opioid Policy Statement – Journal Feed
WHO: COVID-19 disrupting mental health services in most countries
7 Oct, 2020 | 09:24h | UTCCOVID-19 disrupting mental health services in most countries, WHO survey – World Health Organization
ACP Guidance: Should Remdesivir be used for the treatment of patients with COVID-19?
7 Oct, 2020 | 09:21h | UTCSystematic review: Remdesivir for Adults With COVID-19: A Living Systematic Review for an American College of Physicians Practice Points – Annals of Internal Medicine
Flurry of coronavirus reinfections leaves scientists puzzled
7 Oct, 2020 | 09:15h | UTCFlurry of coronavirus reinfections leaves scientists puzzled – The Guardian
Face masks: what the data say
7 Oct, 2020 | 09:17h | UTCFace masks: what the data say – Nature
Commentary on Twitter
#Facemasks: what the data say.#Masks work, but they are not infallible.
You decrease your risk of contagion if you wear them properly AND apply other #hygiene measures, keep your physical distance, and ventilate indoor spaces well.#covid #covid19
https://t.co/uNqehIC2pF— Vanessa Campo-Ruiz, MD PhD (@VCSTX) October 6, 2020
Covid-19: Risk of death more than doubled in people who also had flu, English data show
7 Oct, 2020 | 09:11h | UTCCovid-19: Risk of death more than doubled in people who also had flu, English data show – The BMJ
Original study (preprint): Interactions between SARS-CoV-2 and Influenza and the impact of coinfection on disease severity: A test negative design – medRxiv
Commentary on Twitter
People infected with both flu and SARS-CoV-2 are more than twice as likely to die as someone with the new coronavirus alone, emerging evidence analysed by @PHE_uk has found. The data has been published as a preprint on medRxivhttps://t.co/3Qv3gxGRXB
— The BMJ (@bmj_latest) September 23, 2020
Systematic Review: Thoracic imaging tests for the diagnosis of COVID‐19
7 Oct, 2020 | 09:07h | UTCThoracic imaging tests for the diagnosis of COVID‐19 – Cochrane Library
Commentaries: How accurate is chest imaging for diagnosing COVID-19? – Cochrane Library AND Featured Review: Thoracic imaging tests for the diagnosis of COVID-19 – Cochrane Library